Recent studies have revealed a correlation between drugs such as Ozempic and similar GLP-1 medications like Wegovy and Mounjaro. dpa/picture alliance via Getty Images “I was devastated,” he said.

Like many pharma stocks, Eli Lilly (NYSE: LLY) offers investors a bit of safety -- and it's an element you can count on ...

Novo Nordisk stock was down more than 8% Monday morning after the Danish drugmaker shared new data on its next-generation GLP ...

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

Mounjaro, a newly launched weight-loss and diabetes drug, is now available in India. Developed by Eli Lilly, it promises more ...

Comedian Amy Schumer shared on Instagram that she has been having a 'really good experience' taking the weight loss drug Mounjaro. In a video she filmed from her car, Schumer also said that she is ...

The drug will be priced at ₹3,500 for a 2.5 mg vial and ₹4,375 for the 5 mg vial. The injectable, to be taken once a week, ...

Mounjaro is currently prescribed for individuals with Type 2 diabetes who struggle with blood sugar control. The future of weight management is here. Packaged as an injection, Mounjaro ...

Lilly beats Novo Nordisk to launch weight-loss drug in India Mounjaro's 5 mg vial priced at ... as much as 2.07% to $854.39 on Thursday. Novo's stock has fallen over 12% so far this year, while ...

The much-awaited weightloss and diabetes drug, Mounjaro from US-based Eli Lilly and Company will be available at local chemists in a few weeks, at an India-specific price. Globally Mounjaro ...